Firas Al Kawas


1979 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Firas Al Kawas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Endoscopic Retrograde Cholangiopancreatography Medicine & Life Sciences
Polyps Medicine & Life Sciences
Colonoscopy Medicine & Life Sciences
Endoscopy Medicine & Life Sciences
Stents Medicine & Life Sciences
Pancreatitis Medicine & Life Sciences
Gallstones Medicine & Life Sciences
Lithotripsy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial

Pohl, H., Grimm, I. S., Moyer, M. T., Hasan, M. K., Pleskow, D., Elmunzer, B. J., Khashab, M., Sanaei, O., Al Kawas, F., Gordon, S. R., Mathew, A., Levenick, J. M., Aslanian, H. R., Antaki, F., von Renteln, D., Crockett, S. D., Rastogi, A., Gill, J. A., Law, R. J., Elias, P. A. & 4 others, Pellise, M., Wallace, M. B., Mackenzie, T. A. & Rex, D. K., Oct 1 2019, In : Gastroenterology. 157, 4, p. 977-984.e3

Research output: Contribution to journalArticle

Surgical Instruments
Control Groups

Pancreatic safety in studies of the glucagon-like peptide-1 receptor agonist albiglutide

Al Kawas, F., Ann Anderson, M., Enns, R., Wilson, T. H., Johnson, S. & Mallory, J. M., Jul 1 2019, In : Endocrine Practice. 25, 7, p. 698-716 19 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide-1 Receptor
rGLP-1 protein

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Harmony Outcomes committees and investigators, Oct 27 2018, In : The Lancet. 392, 10157, p. 1519-1529 11 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Cardiovascular Diseases
Randomized Controlled Trials
rGLP-1 protein

Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: Study protocol for a randomized controlled trial

INTERCPT Study Group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE), Feb 14 2018, In : Trials. 19, 1, 108.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Random Allocation
Pancreatic Ducts